Alterity Therapeutics ATHE
NASDAQ ATHE
$2.09 -0.06 (-2.83%)
As of: Oct 23, 2026 · 3:59 PM EDT

Alterity Therapeutics (ATHE) Income towards Parent Company (2016 - 2018)

Updated

Alterity Therapeutics (ATHE) reported Income towards Parent Company of -$16.6 trillion for the year ended Jun 30, 2026, compared with -$7.78 trillion a year earlier.

Analysis

Alterity Therapeutics (ATHE) Income towards Parent Company (2016 - 2018) Analysis & Trends

Dating back to the year ended Jun 30, 2009, Alterity Therapeutics' Income towards Parent Company record includes 18 years.

  • The figure for the year ended Jun 30, 2026 ranks as the lowest annual Income towards Parent Company in data going back to the year ended Jun 30, 2009.
  • According to Business Quant data, Income towards Parent Company came in at -$7.78 trillion in the year ended Jun 30, 2025, -$191,235 in the year ended Aug 29, 2024, -$138,065 in the year ended Dec 31, 2023 and $9.2 million in the year ended Jun 30, 2022 (-21.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Alterity Therapeutics 36.13 Mn -47.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -3.83 Mn
Dec 31, 2017 -2.78 Mn
Dec 31, 2016 -2.74 Mn
API Access

Alterity Therapeutics Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ATHE&period=max&api_key=YOUR_API_KEY